Aliskiren/amlodipine/hydrochlorothiazide

The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved in the United States on 21 December 2010.[1][2]

Aliskiren/amlodipine/hydrochlorothiazide

Combination of
Aliskiren	Renin inhibitor
Amlodipine	Calcium channel blocker
Hydrochlorothiazide	Diuretic
Clinical data
Trade names	Amturnide
AHFS/Drugs.com	Micromedex Detailed Consumer Information
License data	US DailyMed: Amturnide US FDA: Amturnide
Routes of administration	By mouth
ATC code	C09XA54 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
PubChem CID	56841821
KEGG	D10291
Chemical and physical data
Formula	C57H86Cl2N8O15S2
Molar mass	1258.38 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
InChI InChI=1S/C30H53N3O6.C20H25ClN2O5.C7H8ClN3O4S2/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);5-8,17,23H,4,9-11,22H2,1-3H3;1-2,10-11H,3H2,(H2,9,12,13)/t22-,23+,24-,25-;;/m0../s1 Key:YJDDFLDXUPNQTO-WMEHTASQSA-N
(verify)

References

1. Amturnide approval letter. U.S. Food and Drug Administration (FDA).
2. "Drug Approval Package: Amturnide(amlodipine/aliskiren/hydrochlorothiazide) NDA #200045". U.S. Food and Drug Administration (FDA). 15 August 2011. Retrieved 27 August 2020. Lay summary (PDF).

External links

• "Aliskiren mixture with amlodipine and hydrochlorothiazide". Drug Information Portal. U.S. National Library of Medicine.